Succes of labor induction methods in obese women: A scoping review
Article Sidebar
Main Article Content
Abstract
Background
Obese women require labor induction more often than lean women, but induction in this group is less often successful, and the best method has not been established. The aim of this scoping review was to examine available evidence of the success of different induction methods in obese women.
Methods
We searched PubMed, Embase and Web of Science as well as bibliographies for studies of labor induction in obese women. Search terms included “obesity”, “induction of labor”, “cesarean section”, “misoprostol”, “amniotomy” and “mechanical induction”. Studies reporting outcomes of specific methods of labor induction in obese women were included, with cesarean section as the primary outcome.
Results
The search identified 644 studies, of which 27 were included, most of these were retrospective. There was a tendency towards more doses of misoprostol needed for the obese, but no benefit of using 50µg compared to 25µg oral misoprostol. Vaginal delivery rates rose with more days of misoprostol administration. Vaginal misoprostol seemed to be more efficient in the obese compared to oral misoprostol, with shorter time to delivery and more vaginal deliveries, but it might also carry a higher risk of uterine hyperstimulation. Evidence of the efficiency of Foley or balloon catheters in the obese was insufficient. Amniotomy led to more cesarean sections if performed at less than 4 cm of cervical dilation
Conclusion
The available evidence indicates that vaginal misoprostol might be more efficient than oral in obese parturients, and that obese women might have a better chance of achieving vaginal labor after multiple days of induction. Amniotomy at less than 4 cm of cervical dilation leads to higher risk of cesarean section in the obese. There is a lack of randomized trials examining labor induction in the obese.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
CC BY. The paper and it's contents belong to the author, and can be used by others when giving appropriate credit to the authors and the creator (DJOG).
How to Cite
References
1. WHO. Obesity and overweight 2018 [updated 1/3 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.
2. Nyfødte og fødsler (1997-) esundhed.dk: Sundhedsdatastyrelsen; 2024 [updated 06-2024; cited 2024 12/12]. Available from: https://www.esundhed.dk/Emner/Graviditet-foedsler-og-boern/Nyfoedte-og-foedsler-1997-#tabpanel6B95F8298EB444F48C3403E7B75B7202.
3. Creanga AA, Catalano PM, Bateman BT. Obesity in Pregnancy. N Engl J Med. 2022;387(3):248-59. DOI: https://doi.org/10.1056/NEJMra1801040
4. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311(15):1536-46. DOI: https://doi.org/10.1001/jama.2014.2269
5. Eberle A, Czuzoj-Shulman N, Abenhaim HA. Timing of delivery in obese women and risk of stillbirth. J Matern Fetal Neonatal Med. 2022;35(25):7771-7. DOI: https://doi.org/10.1080/14767058.2021.1937107
6. Nohr EA, Villamor E, Vaeth M, Olsen J, Cnattingius S. Mortality in infants of obese mothers: is risk modified by mode of delivery? Acta Obstet Gynecol Scand. 2012;91(3):363-71. DOI: https://doi.org/10.1111/j.1600-0412.2011.01331.x
7. Hedegaard M, Lidegaard O, Skovlund CW, Morch LS, Hedegaard M. Reduction in stillbirths at term after new birth induction paradigm: results of a national intervention. BMJ Open. 2014;4(8):e005785. DOI: https://doi.org/10.1136/bmjopen-2014-005785
8. Ruhstaller K. Induction of labor in the obese patient. Semin Perinatol. 2015;39(6):437-40. DOI: https://doi.org/10.1053/j.semperi.2015.07.003
9. Ellis JA, Brown CM, Barger B, Carlson NS. Influence of Maternal Obesity on Labor Induction: A Systematic Review and Meta-Analysis. J Midwifery Womens Health. 2019;64(1):55-67. DOI: https://doi.org/10.1111/jmwh.12935
10. Yount SM, Lassiter N. The pharmacology of prostaglandins for induction of labor. J Midwifery Womens Health. 2013;58(2):133-44; quiz 238-9. DOI: https://doi.org/10.1111/jmwh.12022
11. de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, et al. Mechanical methods for induction of labour. Cochrane Database Syst Rev. 2023;3(3):CD001233. DOI: https://doi.org/10.1002/14651858.CD001233.pub4
12. Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2014;2014(6):CD001338. DOI: https://doi.org/10.1002/14651858.CD001338.pub3
13. Ornat L, Alonso-Ventura V, Bueno-Notivol J, Chedraui P, Perez-Lopez FR, Health O, et al. Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials. J Matern Fetal Neonatal Med. 2020;33(20):3453-68. DOI: https://doi.org/10.1080/14767058.2019.1574741
14. Bodin CB, Sidsel; Brülle, Anne-Line; Brønd, Marie; Greve, Tine; Hvidman, Lone; Krogh, Lise Qvirin; Lindblad, Juni E.; Nezam, Homaira; Smed, Mette Kiel; Sundtoft, Iben; Thagaard, Ida. Igangsættelse af fødsel – metoder. DSOG. 2014.
15. Carlson NS, Hernandez TL, Hurt KJ. Parturition dysfunction in obesity: time to target the pathobiology. Reprod Biol Endocrinol. 2015;13:135. DOI: https://doi.org/10.1186/s12958-015-0129-6
16. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467-73. DOI: https://doi.org/10.7326/M18-0850
17. Covidence systematic review software. Veritas Health Innovation; 2024.
18. Battarbee AN, Glover AV, Stamilio DM. Association between early amniotomy in labour induction and severe maternal and neonatal morbidity. Aust N Z J Obstet Gynaecol. 2020;60(1):108-14. DOI: https://doi.org/10.1111/ajo.13031
19. Battarbee AN, Vaz S, Stamilio DM. The association between delayed amniotomy and adverse outcomes in labor induction. Eur J Obstet Gynecol Reprod Biol. 2020;247:85-9. DOI: https://doi.org/10.1016/j.ejogrb.2020.02.002
20. Beckwith L, Magner K, Kritzer S, Warshak CR. Prostaglandin versus mechanical dilation and the effect of maternal obesity on failure to achieve active labor: a cohort study. J Matern Fetal Neonatal Med. 2017;30(13):1621-6. DOI: https://doi.org/10.1080/14767058.2016.1220523
21. Bender WR, McCoy JA, Levine LD. Oxytocin vs oral misoprostol for PROM induction in nulliparas with unfavorable cervix: a randomized trial. Am J Obstet Gynecol MFM. 2024;6(8):101414. DOI: https://doi.org/10.1016/j.ajogmf.2024.101414
22. Brewton A, Lilly K, Maples J, Mastronardi A, Young ML, Shore S, et al. 671 Impact of amniotomy timing after foley bulb on induction of labor outcomes in obese patients. American Journal of Obstetrics and Gynecology. 2024;230(1):S360-S1. DOI: https://doi.org/10.1016/j.ajog.2023.11.697
23. Croll DMR, De Vaan MDT, Moes SL, Bloemenkamp KWM, Ten Eikelder MLG, De Heus R, et al. Methods of induction of labor in women with obesity: A secondary analysis of two multicenter randomized controlled trials. Acta Obstet Gynecol Scand. 2024;103(3):470-8. DOI: https://doi.org/10.1111/aogs.14737
24. Durie D, Campbell N, Pressman E, Hackney D. 297: The impact of body mass index on the course of oxytocin labor induction. American Journal of Obstetrics and Gynecology. 2011;204(1). DOI: https://doi.org/10.1016/j.ajog.2010.10.315
25. Estrade M, Diguisto C, Arnaud C, Ehlinger V, Vayssiere PC. Comparison of cesarean delivery rates after 3 methods of cervical ripening among obese women at or after 41 weeks - Secondary analysis of two French randomized controlled trials: MAGPOP and CYTOPRO. Eur J Obstet Gynecol Reprod Biol. 2023;291:16-21. DOI: https://doi.org/10.1016/j.ejogrb.2023.09.019
26. Ferrazzi EM, Paganelli AM, Brembilla G, Urban G, Bonito M, Fossa D, et al. Healthy Foetuses. Misoprostol Insert Induction HF MIND. A multicentre Italian study on the misoprostol vaginal insert for induction of labour. Italian Journal of Gynaecology and Obstetrics. 2021;33(03). DOI: https://doi.org/10.36129/jog.33.03.04
27. Filgueira GCO, Benzi JRL, Rodrigues GFP, Marques MP, Thomaz ML, Duarte G, et al. Vaginal Misoprostol Pharmacokinetic Changes in Obese Parturient Women Who Presented Labor Induction Failure. J Clin Pharmacol. 2024. DOI: https://doi.org/10.1002/jcph.6166
28. Gomez Slagle HB, Kawakita T, Hoffman MK, Sciscione AC, Ma'ayeh M. Buccal versus Vaginal Misoprostol Combined with a Foley Catheter among Individuals with Obesity Undergoing Induction. Am J Perinatol. 2024;41(13):1748-54. DOI: https://doi.org/10.1055/a-2308-2220
29. Guerby P, Berveiller P, Garabedian C, Sentilhes L, Perrotin F, Winer N, et al. 78 Foley catheter+oral misoprostol versus misoprostol for cervical ripening in nulliparous-obese women: a French multicenter RCT. American Journal of Obstetrics and Gynecology. 2024;230(1):S58-S9. DOI: https://doi.org/10.1016/j.ajog.2023.11.101
30. Handal-Orefice RC, Friedman AM, Chouinard SM, Eke AC, Feinberg B, Politch J, et al. Oral or Vaginal Misoprostol for Labor Induction and Cesarean Delivery Risk. Obstet Gynecol. 2019;134(1):10-6. DOI: https://doi.org/10.1097/AOG.0000000000003274
31. Helmig RB, Brogaard L, Hvidman L. Women's body mass index and oral administration of Misoprostol for induction of labor - A retrospective cohort study. Obes Res Clin Pract. 2021;15(5):509-11. DOI: https://doi.org/10.1016/j.orcp.2021.09.001
32. Hermesch AC, Hart KD, Brookfield KF, Caughey AB, Snowden JM. 300: Maximum oxytocin dose and vaginal delivery: Differences by maternal BMI during induction of labor. American Journal of Obstetrics and Gynecology. 2019;220(1). DOI: https://doi.org/10.1016/j.ajog.2018.11.321
33. Hill M, Reed KL, Cohen WR. Oxytocin utilization for labor induction in obese and lean women. J Perinat Med. 2015;43(6):703-6. DOI: https://doi.org/10.1515/jpm-2014-0134
34. Kehl S, Born T, Weiss C, Faschingbauer F, Pretscher J, Beckmann MW, et al. Induction of labour with sequential double-balloon catheter and oral misoprostol versus oral misoprostol alone in obese women. Eur J Obstet Gynecol Reprod Biol X. 2019;3:100034. DOI: https://doi.org/10.1016/j.eurox.2019.100034
35. Lassiter JR, Holliday N, Lewis DF, Mulekar M, Abshire J, Brocato B. Induction of labor with an unfavorable cervix: how does BMI affect success? (double dagger). J Matern Fetal Neonatal Med. 2016;29(18):3000-2. DOI: https://doi.org/10.3109/14767058.2015.1112371
36. Grange J, Dimet J, Vital M, Le Thuaut A, Ducarme G. [Double-balloon catheter compared to vaginal dinoprostone for cervical ripening in obese women at term]. Gynecol Obstet Fertil Senol. 2017;45(10):521-7. DOI: https://doi.org/10.1016/j.gofs.2017.06.012
37. Minor K, Leung K, Allocco ER, Knutson KB, Delpapa E, Lauring J. Early Versus Late Amniotomy During Induction of Labor in Obese Gravida [37I]. Obstetrics & Gynecology. 2019;133(1):105S-S. DOI: https://doi.org/10.1097/01.AOG.0000558814.47741.5c
38. Pasko DN, Miller KM, Jauk VC, Subramaniam A. Pregnancy Outcomes after Early Amniotomy among Class III Obese Gravidas Undergoing Induction of Labor. Am J Perinatol. 2019;36(5):449-54. DOI: https://doi.org/10.1055/s-0038-1675331
39. Saucedo AM, Alvarez M, Macones GA, Cahill AG, Harper LM. Optimal misoprostol dosing among patients with a body mass index greater than 30: a randomized controlled trial. Am J Obstet Gynecol. 2024;230(5):565 e1- e16. DOI: https://doi.org/10.1016/j.ajog.2024.02.004
40. Sfregola G, Sfregola P, Ruta F, Zendoli F, Musicco A, Garzon S, et al. Effect of maternal age and body mass index on induction of labor with oral misoprostol for premature rupture of membrane at term: A retrospective cross-sectional study. Open Med (Wars). 2023;18(1):20230747. DOI: https://doi.org/10.1515/med-2023-0747
41. Soni S, Pappas K, Lesser ML, Blitz MJ, Augustine SA, Rochelson B. Is vaginal misoprostol more effective than oral misoprostol for cervical ripening in obese women? J Matern Fetal Neonatal Med. 2020;33(20):3476-83. DOI: https://doi.org/10.1080/14767058.2019.1575684
42. Suidan RS, Rondon KC, Apuzzio JJ, Williams SF. Labor outcomes of obese patients undergoing induction of labor with misoprostol compared to dinoprostone. Am J Perinatol. 2015;30(2):187-92. DOI: https://doi.org/10.1055/s-0034-1381721
43. Varlas VN, Bostan G, Nasui BA, Bacalbasa N, Pop AL. Is Misoprostol Vaginal Insert Safe for the Induction of Labor in High-Risk Pregnancy Obese Women? Healthcare (Basel). 2021;9(4). DOI: https://doi.org/10.3390/healthcare9040464
44. Viteri OA, Tabsh KK, Alrais MA, Salazar XC, Lopez JM, Fok RY, et al. Transcervical Foley Balloon Plus Vaginal Misoprostol versus Vaginal Misoprostol Alone for Cervical Ripening in Nulliparous Obese Women: A Multicenter, Randomized, Comparative-Effectiveness Trial. Am J Perinatol. 2021;38(S 01):e123-e8. DOI: https://doi.org/10.1055/s-0040-1708805
45. Wei RM, Bounthavong M, Hill MG. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial. Am J Obstet Gynecol MFM. 2022;4(4):100627. DOI: https://doi.org/10.1016/j.ajogmf.2022.100627
46. Williams F, Fox C, Martin J, Luo Q, Gala R. Vaginal Versus Oral Administration of Misoprostol for Labor Induction Among Obese Women [28K]. Obstetrics & Gynecology. 2016;127(Supplement 1). DOI: https://doi.org/10.1097/01.AOG.0000483826.32065.d4
47. Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database Syst Rev. 2010;2010(10):CD000941. DOI: https://doi.org/10.1002/14651858.CD000941.pub2
48. Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Dias S, Jones LV, et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ. 2015;350:h217. DOI: https://doi.org/10.1136/bmj.h217
49. Zhang J, Bricker L, Wray S, Quenby S. Poor uterine contractility in obese women. BJOG. 2007;114(3):343-8. DOI: https://doi.org/10.1111/j.1471-0528.2006.01233.x
50. Stefely E, Warshak CR. Contraction frequency after administration of misoprostol in obese versus nonobese women. J Matern Fetal Neonatal Med. 2019;32(21):3526-30. DOI: https://doi.org/10.1080/14767058.2018.1465919
51. Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis. PLoS Med. 2018;15(1):e1002494. DOI: https://doi.org/10.1371/journal.pmed.1002494
52. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007;99 Suppl 2:S160-7. DOI: https://doi.org/10.1016/j.ijgo.2007.09.004
53. Krogh LQ, Glavind J, Henriksen TB, Thornton J, Fuglsang J, Boie S. Full-term induction of labor vs expectant management and cesarean delivery in women with obesity: systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2023;5(5):100909. DOI: https://doi.org/10.1016/j.ajogmf.2023.100909
54. Helmig RB, Hvidman LE. An audit of oral administration of Angusta(R) (misoprostol) 25 microg for induction of labor in 976 consecutive women with a singleton pregnancy in a university hospital in Denmark. Acta Obstet Gynecol Scand. 2020;99(10):1396-402. DOI: https://doi.org/10.1111/aogs.13876
55. Kelly AJ, Alfirevic Z, Ghosh A. Outpatient versus inpatient induction of labour for improving birth outcomes. Cochrane Database Syst Rev. 2013(11):CD007372. DOI: https://doi.org/10.1002/14651858.CD007372.pub3
56. Smyth RM, Markham C, Dowswell T. Amniotomy for shortening spontaneous labour. Cochrane Database Syst Rev. 2013;2013(6):CD006167. DOI: https://doi.org/10.1002/14651858.CD006167.pub4
57. Sundtoft IB, Charlotte; Boie, Sidsel; Brülle, Anne-Line; Brønd, Marie; Greve, Tine; Hvidman, Lone; Krogh, Lise Qvirin; Lindblad, Juni E.; Nezam, Homaira; Smed, Mette Kiel; Thagaard, Ida. Igangsættelse af fødsel – metoder. DSOG. 2021.
58. Ducarme G, Gilman S, Sauvee M, Planche L. Cervical ripening balloon compared with vaginal dinoprostone for cervical ripening in obese women at term: A prospective cohort study. Int J Gynaecol Obstet. 2024;166(3):1068-76. DOI: https://doi.org/10.1002/ijgo.15480
59. Gauthier T, Mazeau S, Dalmay F, Eyraud JL, Catalan C, Marin B, et al. Obesity and cervical ripening failure risk. J Matern Fetal Neonatal Med. 2012;25(3):304-7. DOI: https://doi.org/10.3109/14767058.2011.575485
60. Hadhoum S, Ghesquiere L, Drumez E, Subtil D, Garabedian C. [Comparison of vaginal prostaglandins with oral misoprostol as a second line of cervical ripening after using a cervical balloon catheter]. Gynecol Obstet Fertil Senol. 2024;52(2):68-73. DOI: https://doi.org/10.1016/j.gofs.2023.11.004
61. Khatib N, Dabaja H, Lauterbach R, Beloosesky R, Ginsberg Y, Weiner Z, et al. 790: Outcomes following medical induction compared to mechanical induction of labor in obese pregnant women. American Journal of Obstetrics and Gynecology. 2019;220(1). DOI: https://doi.org/10.1016/j.ajog.2018.11.813
62. Lauterbach R, Ben Zvi D, Dabaja H, Zidan R, Justman N, Vitner D, et al. Vaginal Dinoprostone Insert versus Cervical Ripening Balloon for Term Induction of Labor in Obese Nulliparas-A Randomized Controlled Trial. J Clin Med. 2022;11(8). DOI: https://doi.org/10.3390/jcm11082138